Burning Rock Biotech Limited (BNR) Tops Q3 EPS by 147c

Burning Rock Biotech Limited (NASDAQ: BNR) reported Q3 EPS of (RMB0.31), RMB1.47 better than the analyst estimate of (RMB1.78). Revenue for the quarter came in at RMB21.74 million versus the consensus estimate of RMB156 million.

For earnings history and earnings-related data on Burning Rock Biotech Limited (BNR) click here.

You May Also Be Interested In

• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• Karman Space & Defense acquires Walker Precision Engineering
• Why UBS thinks this European chipmaker is still undervalued despite its premium valuation